预测软组织肉瘤患者的五年死亡率
Teja Yeramosu1, Waleed Ahmad1, Azhar Bashir2
1School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
The bone & joint journal
|May 31, 2023
概括
瘤大小,M阶段和组织学亚型是软组织肉瘤 (STS) 患者五年癌症相关死亡率的关键预测因素. 机器学习模型可以准确预测存活率,帮助肢体和干部STS的治疗决策.
科学领域:
- 在瘤学瘤学.
- 机器学习在医学中的应用
- 生物统计学 生物统计学
背景情况:
- 软组织肉瘤 (STS) 是一种罕见的恶性瘤,预后可变.
- 确定预测癌症相关死亡率的因素对于患者管理至关重要.
- 现有的预测模型可能无法完全捕捉到STS结果的复杂性.
研究的目的:
- 确定与四肢和干部STS五年癌症相关死亡率相关的关键因素.
- 开发和验证用于预测这种死亡率的机器学习 (ML) 算法.
- 为改善风险分层和治疗规划提供工具.
主要方法:
- 从SEER数据库 (2004-2017) 中分析人口统计,临床病理和治疗数据.
- 多变量后勤回归用于识别显著的死亡预测因素.
- 使用AUC,校准和决策曲线分析开发和比较各种ML模型 (例如随机森林).
- 在机构数据集上对表现最好的模型进行外部验证.
主要成果:
- 分析了13,646名STS患者;35.9%的患者经历了五年癌症相关死亡率.
- 随机森林模型表现出卓越的性能.
- 瘤大小是最重要的预测因素,其次是M阶段,组织学亚型,年龄和外科切除.
- 通过外部验证,AUC达到0.752.
结论:
- 确定了用于预测STS死亡率的临床重要变量.
- 一个经过验证的ML模型为癌症相关死亡率提供了良好的准确性和可预测性.
- 这些发现可以帮助骨科瘤学家对患者进行风险分层并优化治疗策略.
更多相关视频
相关概念视频
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Actuarial Approach
101
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
101
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Kaplan-Meier Approach
197
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
197


